Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being studied as an alternative to chemotherapy and radiotherapy. This is because it directly targets cancer cells, reducing the negative effects associated with more conventi
Brain cancer presents a unique set of challenges for researchers because by the time a person develops symptoms, the tumours are sometimes so complicated that the fundamental mechanisms driving tumour growth are no longer easily identifiable. A research team led by Dr. Peter Dirks is aiming
The researchers have identified a rare type of immune cell, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses against cancer and other chronic infections.
New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with better long-term survival than wedge resection for patients with early-stage non-small cell lung cancer (NSCLC)
Researchers at Penn Medicine's Abramson Cancer Centre and the University of Pennsylvania's Perelman School of Medicine have found that a straightforward dietary supplement may offer a novel way to enhance CAR T cell performance.
Researchers at Uppsala University and KTH Royal Institute of Technology have created an antibody that has the potential to treat a variety of cancers. Researchers were able to integrate three different functionalities in the antibody, which combined significantly increased the action of T ce
A recent Cedars-Sinai Cancer study found that up to 80 per cent of the time, patients with early pancreatic cancer are incorrectly staged. The discovery highlights the critical need for improvements in staging and diagnostic technology, which could have a substantial impact on early pancreat
Fatty liver disease frequently causes chronic liver inflammation and can possibly result in liver cancer. Scientists at the German Cancer Research Centre (DKFZ) and the University of Tubingen have demonstrated in mice that intermittent fasting on a 5:2 schedule can block this progression.
For the first time in 50 years, a phase 3 randomised, placebo-controlled trial found that an adjuvant therapy improved overall survival in kidney cancer patients.
Standard chemotherapy regimens, which are primarily based on testing in relatively young and healthy patients, may be more harmful to older persons with cancer, who frequently battle with other health conditions.
According to a new study, a diet low in meat and dairy but high in fruits, vegetables, grains, and nuts is associated with lower rates of erectile dysfunction, urinary incontinence, and other frequent side effects in prostate cancer patients.
A revolutionary study by Case Western Reserve University researchers reveals that a class of medications used to treat type 2 diabetes may also lower the risk of colorectal cancer